Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 18 $ 547
Prepaid expenses 16 112
Total current assets 34 659
Office and lab equipment, net of accumulated depreciation of $10 and $0 350 4
Intangible assets, net of accumulated amortization of $158 and $144 54 68
Goodwill 2,159
Other assets 3 3
Total assets 2,600 734
Current liabilities:    
Accounts payable 1,724 1,238
Accrued expenses 1,093 384
Convertible debentures, net of unamortized discount of $307 2,480
Derivative liability 3,338 2,541
Total current liabilities 8,635 4,163
Total liabilities 8,635 4,163
Commitments and contingencies
Stockholders' deficit:    
Convertible preferred stock, par value $.0001 per share; 30,000,000 shares authorized, 495 and 2,828 shares issued and outstanding, respectively
Common stock, par value $.0001 per share; 150,000,000 shares authorized, 9,075,589 and 1,398,832 shares issued and outstanding, respectively 1
Additional paid-in capital 48,425 45,391
Accumulated deficit (54,461) (48,820)
Total stockholders' deficit (6,035) (3,429)
Total liabilities and stockholders' deficit $ 2,600 $ 734